Approval · Notice of Compliance 31075 · 2023
FENTORA: Notice of Compliance 31075
Issued June 27, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31075
- Date
- June 27, 2023
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Updates to the Product Monograph (PM).
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FENTORA | Not yet assigned | — |
Medicinal ingredients
- FENTANYL CITRATE 100 MCG per TAB
- FENTANYL CITRATE 200 MCG per TAB
- FENTANYL CITRATE 400 MCG per TAB
- FENTANYL CITRATE 600 MCG per TAB
- FENTANYL CITRATE 800 MCG per TAB